Rosuvastatin Evaluation as a Tuberculosis Treatment Adjunct

Summary

Rosuvastatin Evaluation as a Tuberculosis Treatment Adjunct is a clinical trial^[1].

Key Facts

• Rosuvastatin Evaluation as a Tuberculosis Treatment Adjunct is in the country of Philippines^[2].
• Rosuvastatin Evaluation as a Tuberculosis Treatment Adjunct is in the country of Singapore^[3].
• Rosuvastatin Evaluation as a Tuberculosis Treatment Adjunct is in the country of Uganda^[4].
• Rosuvastatin Evaluation as a Tuberculosis Treatment Adjunct is in the country of Vietnam^[5].
• Rosuvastatin Evaluation as a Tuberculosis Treatment Adjunct's instance of is recorded as clinical trial^[6].
• Rosuvastatin Evaluation as a Tuberculosis Treatment Adjunct's start time is recorded as +2020-08-12T00:00:00Z^[7].
• Rosuvastatin Evaluation as a Tuberculosis Treatment Adjunct's end time is recorded as +2021-03-31T00:00:00Z^[8].
• Rosuvastatin Evaluation as a Tuberculosis Treatment Adjunct's main subject is recorded as tuberculosis^[9].
• Rosuvastatin Evaluation as a Tuberculosis Treatment Adjunct's main subject is recorded as gram-positive bacterial infections^[10].
• Rosuvastatin Evaluation as a Tuberculosis Treatment Adjunct's number of participants is recorded as {'unit': '1', 'amount': '+154'}^[11].
• Rosuvastatin Evaluation as a Tuberculosis Treatment Adjunct's title is recorded as Rosuvastatin Evaluation as a Tuberculosis Treatment Adjunct^[12].
• Rosuvastatin Evaluation as a Tuberculosis Treatment Adjunct's short name is recorded as ROSETTA^[13].
• Rosuvastatin Evaluation as a Tuberculosis Treatment Adjunct's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[14].
• Rosuvastatin Evaluation as a Tuberculosis Treatment Adjunct's ClinicalTrials.gov ID is recorded as NCT04504851^[15].
• Rosuvastatin Evaluation as a Tuberculosis Treatment Adjunct's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+75'}^[16].
• Rosuvastatin Evaluation as a Tuberculosis Treatment Adjunct's research intervention is recorded as rifampicin^[17].
• Rosuvastatin Evaluation as a Tuberculosis Treatment Adjunct's research intervention is recorded as isoniazid^[18].
• Rosuvastatin Evaluation as a Tuberculosis Treatment Adjunct's research intervention is recorded as pyrazinamide^[19].
• Rosuvastatin Evaluation as a Tuberculosis Treatment Adjunct's research intervention is recorded as ethambutol^[20].
• Rosuvastatin Evaluation as a Tuberculosis Treatment Adjunct's research intervention is recorded as rosuvastatin calcium^[21].
• Rosuvastatin Evaluation as a Tuberculosis Treatment Adjunct's research intervention is recorded as anticholesteremic agents^[22].
• Rosuvastatin Evaluation as a Tuberculosis Treatment Adjunct's research intervention is recorded as hypolipidemic^[23].
• Rosuvastatin Evaluation as a Tuberculosis Treatment Adjunct's research intervention is recorded as antimetabolite^[24].
• Rosuvastatin Evaluation as a Tuberculosis Treatment Adjunct's research intervention is recorded as mechanism of action^[25].
• Rosuvastatin Evaluation as a Tuberculosis Treatment Adjunct's research intervention is recorded as statin^[26].